Science Explorer Back to mapMap
Discussion
Researcher · Orion Corporation (Finland) · Finland

Juha Kiesvaara

Juha Kiesvaara publishes mostly in Pharmaceutical Science, Materials Chemistry and Dermatology, on topics such as Mesoporous Materials and Catalysis, Advancements in Transdermal Drug Delivery and Advanced Drug Delivery Systems.

OpenAlex
World rank
#425,722
of 7,710,434 ranked researchers
Rank in Finland
#2,494
of 37,370
Works
28
Citations
2.6k
Citations per work
91.2
h-index
22
i10-index 23Top 21% in Pharmaceutical Science
Juha Kiesvaara

What does Juha Kiesvaara research?

Juha Kiesvaara's work is mostly in Materials Science (27%), Pharmacology, Toxicology and Pharmaceutics (21%), Medicine (11%).

Physical Sciences: 11 works · 39.5% of their workMaterials Science: 8 works · 27.2% of their workMaterials Chemistry: 6 works · 19.8% of their workBiomaterials: 2 works · 7.4% of their workEngineering: 2 works · 7.4% of their workBiomedical Engineering: 2 works · 7.4% of their workChemistry: 1 works · 4.9% of their workSpectroscopy: 1 works · 4.9% of their workEverything else: 8 works · 28.4% of their workLife Sciences: 6 works · 21.0% of their workPharmacology, Toxicology and Pharmaceutics: 6 works · 21.0% of their workPharmaceutical Science: 6 works · 21.0% of their workHealth Sciences: 3 works · 11.1% of their workMedicine: 3 works · 11.1% of their workDermatology: 3 works · 11.1% of their workTHEIR WORKJuha Kiesvaara28works
Life Sciences21%Physical Sciences40%Health Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Materials Science827.2%
    2. Engineering27.4%
    3. Chemistry14.9%
  2. Everything else828.4%
    1. Pharmacology, Toxicology and Pharmaceutics621.0%
    1. Medicine311.1%
  1. 1Pharmaceutical Science21% of their works
  2. 2Materials Chemistry20% of their works
  3. 3Dermatology11% of their works
  4. 4Biomedical Engineering7% of their works
  5. 5Biomaterials7% of their works
  6. 6Spectroscopy5% of their works

Research topics

Which keywords describe Juha Kiesvaara's research?

The keywords of their largest research topics: Drug Delivery, Nanocomposites, Mesoporous Materials, Nanocomposite Materials, Biodegradable Polymers, Chitosan, Filaggrin and Microneedles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Drug Delivery142 topics
  2. Nanocomposites102 topics
  3. Mesoporous Materials81 topic
  4. Nanocomposite Materials81 topic
  5. Biodegradable Polymers61 topic
  6. Chitosan61 topic
  7. Filaggrin61 topic
  8. Microneedles61 topic
  9. Nanoparticles61 topic
  10. Polylactic Acid61 topic
  11. Skin Microbiome61 topic
  12. Solid Lipid Nanoparticles61 topic
  13. Biomaterials51 topic
  14. Cyclodextrins51 topic
  15. Scaffolds51 topic
  16. Solid Dispersions51 topic
  17. Aerogels41 topic
  18. Synthesis41 topic

Where does Juha Kiesvaara work?

Juha Kiesvaara's main affiliation in the publication record is Orion Corporation (Finland), Finland.

How many publications and citations does Juha Kiesvaara have?

OpenAlex counts 28 works and 2,553 citations for Juha Kiesvaara, an h-index of 22, ranking #425,722 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Juha Kiesvaara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.